TASZX
Price
$21.55
Change
-$0.01 (-0.05%)
Updated
Dec 2 closing price
Net Assets
175.55M
UBVVX
Price
$83.98
Change
-$0.73 (-0.86%)
Updated
Dec 2 closing price
Net Assets
9.34B
Interact to see
Advertisement

TASZX vs UBVVX

Header iconTASZX vs UBVVX Comparison
Open Charts TASZX vs UBVVXBanner chart's image
Third Avenue Small Cap Value Z
Price$21.55
Change-$0.01 (-0.05%)
VolumeN/A
Net Assets175.55M
Undiscovered Managers Behavioral Val R5
Price$83.98
Change-$0.73 (-0.86%)
VolumeN/A
Net Assets9.34B
TASZX vs UBVVX Comparison Chart in %
View a ticker or compare two or three
VS
TASZX vs. UBVVX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is TASZX is a StrongBuy and UBVVX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
UBVVX has more cash in the bank: 9.34B vs. TASZX (176M). UBVVX pays higher dividends than TASZX: UBVVX (1.84) vs TASZX (0.58). TASZX was incepted earlier than UBVVX: TASZX (8 years) vs UBVVX (9 years). TASZX (1.18) is less costly to investors than UBVVX (0.95). UBVVX is a more actively managed with annual turnover of: 35.00 vs. TASZX (15.00). UBVVX has a lower initial minimum investment than TASZX: UBVVX (0) vs TASZX (25000). TASZX annual gain was more profitable for investors over the last year : -4.30 vs. UBVVX (-8.74). UBVVX return over 5 years is better than : 44.08 vs. TASZX (24.72).
TASZXUBVVXTASZX / UBVVX
Total Expense Ratio1.080.90120%
Annual Report Gross Expense Ratio1.180.95124%
Fund Existence8 years9 years-
Gain YTD14.3160.8691,647%
Front LoadN/AN/A-
Min. Initial Investment250000-
Min. Initial Investment IRAN/AN/A-
Net Assets176M9.34B2%
Annual Yield % from dividends0.581.8432%
Returns for 1 year-4.30-8.7449%
Returns for 3 years4.832.58187%
Returns for 5 years24.7244.0856%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MIDHX32.66N/A
N/A
MFS International New Discovery R3
PSTAX21.57N/A
N/A
Virtus KAR Capital Growth A
UPUPX12.47N/A
N/A
Upright Growth
FMCVX26.59N/A
N/A
Franklin Mutual Small-Mid Cap Val R6
FIJYX43.03N/A
N/A
Fidelity Advisor Biotechnology Z